First Pharmaceutical announced that the company's 2026 semi-annual performance briefing was held through the Shanghai Stock Exchange Roadshow Center. In the first half year of 2026, the company achieved operating income of 982 million yuan, a year-on-year decrease of 1.51%; net profit to mother was 26.17 million yuan, an increase of 86.60%; net profit after deducting non-return to mother was 1.31 million yuan, a year-on-year decrease of 85.44%. The company's 2025 profit distribution plan is to distribute a cash dividend of 0.78 yuan for every 10 shares, which was implemented in June 2026. Currently, no other risk warnings have been implemented, the company has maintained profits for three consecutive years, and the internal control system is operating effectively.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.